SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

Saved in:
Bibliographic Details
Published inHematology, Transfusion and Cell Therapy Vol. 42; pp. 57 - 58
Main Authors Barros, M.M.O., Röth, A., Barcellini, W., Tvedt, T.H.A., Miyakawa, Y., Kuter, D.J., Hobbs, W., Su, J., Jiang, X., Arias, J.M., Weitz, I.C.
Format Journal Article
LanguageEnglish
Published Elsevier Editora Ltda 01.11.2020
Elsevier
Online AccessGet full text

Cover

More Information
ISSN:2531-1379
DOI:10.1016/j.htct.2020.10.095